Board to approve September 2026 quarterly and half-year results
CRAVATEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.6 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Cravatex will hold a board meeting on 3 November 2026 to approve unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The filing provides no performance figures.
The results may influence investor sentiment, but the filing gives no figures to assess profitability, cash flow or financial health.